GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
12/06/25	GSK	11:00:00	12 Jun 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK plc	PRN
21/02/25	GSK	07:00:12	21 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
21/02/25	GSK	07:00:11	21 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
21/02/25	GSK	07:00:09	21 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
21/02/25	GSK	07:00:08	21 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
21/02/25	GSK	07:00:07	21 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
21/02/25	GSK	07:00:01	21 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
20/02/25	GSK	07:00:07	20 Feb 2025	Nucala COPD submission accepted in China	GSK	Nucala COPD submission accepted in China	GSK PLC	RNS
17/02/25	GSK	07:00:06	17 Feb 2025	GSK 5-in-1 meningitis vaccine approved by US FDA	GSK	GSK 5-in-1 meningitis vaccine approved by US FDA	GSK PLC	RNS
13/02/25	GSK	15:30:00	13 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/02/25	GSK	15:30:01	11 Feb 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
05/02/25	GSK	07:00:03	5 Feb 2025	Final Results	GSK	Final Results	GSK PLC	RNS
03/02/25	GSK	16:48:29	3 Feb 2025	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
28/01/25	GSK	07:05:00	28 Jan 2025	Depemokimab dual filing in China and Japan	GSK	Depemokimab dual filing in China and Japan	GSK PLC	RNS
28/01/25	GSK	07:00:02	28 Jan 2025	EMA accepts two submissions for depemokimab	GSK	EMA accepts two submissions for depemokimab	GSK PLC	RNS
27/01/25	GSK	07:05:00	27 Jan 2025	EMA accept review Shingrix syringe presentation	GSK	EMA accept review Shingrix syringe presentation	GSK PLC	RNS
20/01/25	GSK	07:00:05	20 Jan 2025	Jemperli expanded approval in the EU	GSK	Jemperli expanded approval in the EU	GSK PLC	RNS
16/01/25	GSK	15:30:00	16 Jan 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
15/01/25	GSK	15:30:00	15 Jan 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
14/01/25	GSK	15:30:00	14 Jan 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
13/01/25	GSK	15:30:00	13 Jan 2025	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
13/01/25	GSK	07:00:05	13 Jan 2025	GSK enters agreement to acquire IDRx, Inc.	GSK	GSK enters agreement to acquire IDRx, Inc.	GSK PLC	RNS
10/01/25	GSK	07:00:05	10 Jan 2025	Shingrix fully liquid accepted for US FDA review	GSK	Shingrix fully liquid accepted for US FDA review	GSK PLC	RNS
07/01/25	GSK	07:00:05	7 Jan 2025	GSK ADC gets FDA breakthrough therapy designation	GSK	GSK ADC gets FDA breakthrough therapy designation	GSK PLC	RNS
03/01/25	GSK	07:00:02	3 Jan 2025	GSK’s Nucala approved in China for use in CRSwNP	GSK	GSK’s Nucala approved in China for use in CRSwNP	GSK PLC	RNS
02/01/25	GSK	15:00:01	2 Jan 2025	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
23/12/24	GSK	15:30:01	23 Dec 2024	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
20/12/24	GSK	09:00:01	20 Dec 2024	Block Listing Application	GSK	Block Listing Application	GSK PLC	RNS
20/12/24	GSK	07:00:07	20 Dec 2024	Headline results from phase III FIRST trial	GSK	Headline results from phase III FIRST trial	GSK PLC	RNS
16/12/24	GSK	07:11:13	16 Dec 2024	Jemperli receives US FDA breakthrough designation	GSK	Jemperli receives US FDA breakthrough designation	GSK PLC	RNS
16/12/24	GSK	07:05:00	16 Dec 2024	EMA grants PRIME Designation for GSK’227	GSK	EMA grants PRIME Designation for GSK’227	GSK PLC	RNS
16/12/24	GSK	07:00:03	16 Dec 2024	Jemperli receives positive CHMP opinion	GSK	Jemperli receives positive CHMP opinion	GSK PLC	RNS
12/12/24	GSK	15:30:00	12 Dec 2024	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
09/12/24	GSK	18:29:00	9 Dec 2024	Overall survival data presented for Blenrep	GSK	Overall survival data presented for Blenrep	GSK PLC	RNS
09/12/24	GSK	07:05:00	9 Dec 2024	Blenrep combination China filing acceptance	GSK	Blenrep combination China filing acceptance	GSK PLC	RNS
09/12/24	GSK	07:00:05	9 Dec 2024	Nucala COPD submission accepted by US FDA	GSK	Nucala COPD submission accepted by US FDA	GSK PLC	RNS
05/12/24	GSK	07:00:22	5 Dec 2024	Zhifei China collaboration revised and extended	GSK	Zhifei China collaboration revised and extended	GSK PLC	RNS
02/12/24	GSK	15:30:00	2 Dec 2024	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
02/12/24	GSK	15:00:00	2 Dec 2024	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
27/11/24	GSK	07:00:03	27 Nov 2024	GSK liquid meningitis vaccine authorised in EU	GSK	GSK liquid meningitis vaccine authorised in EU	GSK PLC	RNS
25/11/24	GSK	07:00:04	25 Nov 2024	Blenrep combinations accepted for US FDA review	GSK	Blenrep combinations accepted for US FDA review	GSK PLC	RNS
22/11/24	GSK	07:00:06	22 Nov 2024	Japan approves first RSV vaccine for adults 50-59	GSK	Japan approves first RSV vaccine for adults 50-59	GSK PLC	RNS
19/11/24	GSK	15:30:01	19 Nov 2024	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
19/11/24	GSK	07:00:08	19 Nov 2024	GLISTEN Trial of Linerixibat Meets Endpoint	GSK	GLISTEN Trial of Linerixibat Meets Endpoint	GSK PLC	RNS
14/11/24	GSK	07:00:10	14 Nov 2024	GSK announces overall survival results for Blenrep	GSK	GSK announces overall survival results for Blenrep	GSK PLC	RNS
13/11/24	GSK	15:00:00	13 Nov 2024	Block listing Interim Review	GSK	Block listing Interim Review	GSK PLC	RNS
12/11/24	GSK	15:30:00	12 Nov 2024	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/11/24	GSK	15:01:18	11 Nov 2024	GSK publishes provisional 2025 dividend dates	GSK	GSK publishes provisional 2025 dividend dates	GSK PLC	RNS
01/11/24	GSK	15:00:00	1 Nov 2024	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
30/10/24	GSK	14:29:00	30 Oct 2024	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS

Showing 501–550 of 2,803 announcements